Principles for interactions with biopharmaceutical companies: the development of guidelines for patient advocacy organizations in the field of rare diseases

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#6 of 3,043)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 48 news outlets
twitter: 46 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 72 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Lipodystrophy United, 06 Feb 2018

Incredibly important! I’d like to see these guidelines used in practice consistently among pharma. #patientadvocacy #bestpractice…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.